GESIDA/PETHEMA recommendations on the diagnosis and treatment of lymphomas in patients infected by the human immunodeficiency virus.

Authors :: Miralles P
Navarro JT
Berenguer J
Gómez Codina J
Kwon M
Serrano D
Díez-Martín JL
Villà S
Rubio R
Menárguez J
Ribera Santasusana JM
Source :: Medicina clinica [Med Clin (Barc)] 2018 Jul 13; Vol. 151 (1), pp. 39.e1-39.e17. Date of Electronic Publication: 2018 Jan 19.
Publication Year :: 2018
Abstract: The incidence of non-Hodgkin's lymphoma and Hodgkin's lymphoma is higher in patients with HIV infection than in the general population. Following the introduction of combination antiretroviral therapy (cART), the prognostic significance of HIV-related variables has decreased, and lymphoma-related factors have become more pronounced. Currently, treatments for lymphomas in HIV-infected patients do not differ from those used in the general population. However, differentiating characteristics of seropositive patients, such as the need for cART and specific prophylaxis and treatment of certain opportunistic infections, should be considered. This document updates recommendations on the diagnosis and treatment of lymphomas in HIV infected patients published by GESIDA/PETHEMA in 2008.<br /> (Copyright © 2017 Elsevier España, S.L.U. All rights reserved.)

Subjects :: Anti-HIV Agents therapeutic use
Combined Modality Therapy
HIV Infections drug therapy
Humans
Prognosis
HIV Infections complications
Hodgkin Disease complications
Hodgkin Disease diagnosis
Hodgkin Disease therapy
Lymphoma, Non-Hodgkin complications
Lymphoma, Non-Hodgkin diagnosis
Lymphoma, Non-Hodgkin therapy

Full Text Access

Tools